Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Nerve block may ease shoulder pain and improve movement in stroke survivors

NCT ID NCT07346755

Symptom relief Sponsor: Fatih Sultan Mehmet Training and Research Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a suprascapular nerve block (a numbing injection) plus physical therapy can improve shoulder joint awareness and reduce pain in stroke survivors with hemiplegic shoulder pain. Fourteen participants will be randomly assigned to receive either the nerve block followed by physical therapy or physical therapy alone. The goal is to see if the nerve block helps with movement sense, pain, and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
suprascapular nerve block (injection of lidocaine)
What this could lead to
If it works, this could point toward a better way to manage shoulder pain and improve movement awareness in stroke survivors.
What could go wrong
This is a very small, early-stage trial with only 14 participants, so results may not apply widely. The nerve block is temporary and not a long-term solution.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2025

Expected to finish

May 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between 18 and 80 years * Presence of shoulder pain on the hemiplegic side with a Numeric Rating Scale (NRS) score \> 3 * At least 1 month since the cerebrovascular event (subacute and chronic stroke patients) * Active shoulder flexion range of motion \> 90 degrees (required for the application of the laser pointer-assisted joint position sense test) * First-ever, unilateral hemiplegia Exclusion Criteria: * Mini-Mental State Examination score \< 24 indicating cognitive impairment * Presence of aphasia * Shoulder spasticity with a Modified Ashworth Scale score \> 2 * Brunnstrom upper extremity motor stage \< 3 * Botulinum toxin type A injection within the last 3 months to muscles affecting shoulder joint movement (trapezius, levator scapulae, pectoralis major, deltoid, serratus anterior, latissimus dorsi, rhomboids, teres major, biceps, coracobrachialis, triceps, supraspinatus, subscapularis, infraspinatus, and teres minor) * Pre-existing shoulder pathology causing pain in the hemiplegic shoulder * Presence of neglect syndrome * Complex regional pain syndrome, central pain, traumatic brachial plexus injury * Change in pain medication during the study period * Hypersensitivity to the medication used for suprascapular nerve block (lidocaine) * Adhesive capsulitis (frozen shoulder) * Other shoulder pathologies such as fractures or joint replacement

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemiplegic shoulder pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hemiplegia stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hemiplegic shoulder pain Proprioception Suprascapular nerve block

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Fatih Sultan Mehmet Training and Research Hospital Istanbul, İstanbul, Turkey

    RECRUITING

    Istanbul, Istanbul, 34752, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.